⌘K

Login Start Free

Home/Filings/4/0001213900-24-015703

4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-24-015703

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 2:58 PM ET

Size

4.6 KB

Accession

0001213900-24-015703

Insider Transaction Report

Form 4

Period: 2024-02-20

InMed Pharmaceuticals Inc.INM

DirectorCEO & President10% Owner

Transactions

Purchase
Common Stock
2024-02-20$0.36/sh+41,600$14,922→ 43,959 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001817882

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 2:58 PM ET
Size: 4.6 KB

View on SEC.gov